05:38 PM EDT, 10/08/2025 (MT Newswires) -- Ivan Hyep, Chief Financial Officer, on October 06, 2025, sold 30,385 shares in Bicara Therapeutics ( BCAX ) for $553,198. Following the Form 4 filing with the SEC, Hyep has control over a total of 145,355 common shares of the company, with 145,355 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203466825000004/xslF345X05/wk-form4_1759959228.xml ...

* Lawmaker groups agree to further weaken corporate sustainability law * Deal would apply law to firms with at least 5,000 employees, 1.5 billion euros turnover * Socialists compromise to avoid 'worse' deal with far-right lawmakers By Kate Abnett BRUSSELS, Oct 8 (Reuters) - Lawmaker groups holding a majority in the European Parliament agreed a deal late on Wednesday to...

(Reuters) -U.S. regulators are investigating Massachusetts Mutual Life Insurance over its accounting practices in investment operations, the Wall Street Journal reported on Wednesday. The Securities and Exchange Commission has issued subpoenas seeking information about MassMutual's bookkeeping around income on billions of dollars of loans it holds in its general investment account, the report said, citing people familiar with the matter....

05:39 PM EDT, 10/08/2025 (MT Newswires) -- Ryan Cohlhepp, Director, President and COO, on October 06, 2025, sold 50,500 shares in Bicara Therapeutics ( BCAX ) for $911,842. Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 202,641 common shares of the company, with 202,641 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203466525000004/xslF345X05/wk-form4_1759959205.xml ...